Foot JS, Yow TT, Schilter H, Buson A, Deodhar M, Findlay AD, Guo L, McDonald IA, Turner CI, Zhou W, Jarolimek W (Nov 2013). "PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo". The Journal of Pharmacology and Experimental Therapeutics. 347 (2): 365–74. doi:10.1124/jpet.113.207613. PMID23943052. S2CID6164890.
Januszewski AS, Mason N, Karschimkus CS, Rowley KG, Best JD, O'Neal DN, Jenkins AJ (May 2014). "Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia". Diabetes & Vascular Disease Research. 11 (4): 262–269. doi:10.1177/1479164114532963. PMID24853908. S2CID23326308.
Repessé X, Moldes M, Muscat A, Vatier C, Chetrite G, Gille T, Planes C, Filip A, Mercier N, Duranteau J, Fève B (Aug 2015). "Hypoxia inhibits semicarbazide-sensitive amine oxidase activity in adipocytes". Molecular and Cellular Endocrinology. 411: 58–66. doi:10.1016/j.mce.2015.04.011. PMID25907140. S2CID46505459.
Valente T, Gella A, Solé M, Durany N, Unzeta M (Oct 2012). "Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus". Journal of Neuroscience Research. 90 (10): 1989–96. doi:10.1002/jnr.23092. PMID22714978. S2CID26126297.
Hernandez-Guillamon M, Solé M, Delgado P, García-Bonilla L, Giralt D, Boada C, Penalba A, García S, Flores A, Ribó M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J (2012). "VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke". Cerebrovascular Diseases. 33 (1): 55–63. doi:10.1159/000333370. PMID22133888. S2CID24467635.
Solé M, Unzeta M (Nov 2011). "Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases". Biology of the Cell. 103 (11): 543–57. doi:10.1042/BC20110049. PMID21819380. S2CID4598444.
El-Maghrabey MH, Kishikawa N, Ohyama K, Imazato T, Ueki Y, Kuroda N (Jun 2015). "Determination of human serum semicarbazide-sensitive amine oxidase activity via flow injection analysis with fluorescence detection after online derivatization of the enzymatically produced benzaldehyde with 1,2-diaminoanthraquinone". Analytica Chimica Acta. 881: 139–47. Bibcode:2015AcAC..881..139E. doi:10.1016/j.aca.2015.04.006. hdl:10069/35501. PMID26041530.
Wong M, Saad S, Zhang J, Gross S, Jarolimek W, Schilter H, Chen JA, Gill AJ, Pollock CA, Wong MG (Oct 2014). "Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model". American Journal of Physiology. Renal Physiology. 307 (8): F908–16. doi:10.1152/ajprenal.00698.2013. PMID25143459.
Sun P, Solé M, Unzeta M (2014). "Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia". Cerebrovascular Diseases. 37 (3): 171–80. doi:10.1159/000357660. PMID24503888. S2CID11980778.
Lin MS, Li HY, Wei JN, Lin CH, Smith DJ, Vainio J, Shih SR, Chen YH, Lin LC, Kao HL, Chuang LM, Chen MF (Nov 2008). "Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease". Clinical Biochemistry. 41 (16–17): 1362–7. doi:10.1016/j.clinbiochem.2008.06.019. PMID18644360.
Kaplan MA, Kucukoner M, Inal A, Urakci Z, Evliyaoglu O, Firat U, Kaya M, Isikdogan A (2014). "Relationship between serum soluble vascular adhesion protein-1 level and gastric cancer prognosis". Oncology Research and Treatment. 37 (6): 340–4. doi:10.1159/000362626. PMID24903765. S2CID22849102.
Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S (Aug 2008). "Vascular adhesion protein-1 in human ischaemic stroke". Neuropathology and Applied Neurobiology. 34 (4): 394–402. doi:10.1111/j.1365-2990.2007.00911.x. PMID18005095. S2CID25254193.
Li HY, Wei JN, Lin MS, Smith DJ, Vainio J, Lin CH, Chiang FT, Shih SR, Huang CH, Wu MY, Hsein YC, Chuang LM (Jun 2009). "Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia". Clinica Chimica Acta; International Journal of Clinical Chemistry. 404 (2): 149–53. doi:10.1016/j.cca.2009.03.041. PMID19336232.
El-Maghrabey MH, Kishikawa N, Ohyama K, Imazato T, Ueki Y, Kuroda N (Jun 2015). "Determination of human serum semicarbazide-sensitive amine oxidase activity via flow injection analysis with fluorescence detection after online derivatization of the enzymatically produced benzaldehyde with 1,2-diaminoanthraquinone". Analytica Chimica Acta. 881: 139–47. Bibcode:2015AcAC..881..139E. doi:10.1016/j.aca.2015.04.006. hdl:10069/35501. PMID26041530.
El-Maghrabey MH, Kishikawa N, Ohyama K, Imazato T, Ueki Y, Kuroda N (Jun 2015). "Determination of human serum semicarbazide-sensitive amine oxidase activity via flow injection analysis with fluorescence detection after online derivatization of the enzymatically produced benzaldehyde with 1,2-diaminoanthraquinone". Analytica Chimica Acta. 881: 139–47. Bibcode:2015AcAC..881..139E. doi:10.1016/j.aca.2015.04.006. hdl:10069/35501. PMID26041530.
Foot JS, Yow TT, Schilter H, Buson A, Deodhar M, Findlay AD, Guo L, McDonald IA, Turner CI, Zhou W, Jarolimek W (Nov 2013). "PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo". The Journal of Pharmacology and Experimental Therapeutics. 347 (2): 365–74. doi:10.1124/jpet.113.207613. PMID23943052. S2CID6164890.
Januszewski AS, Mason N, Karschimkus CS, Rowley KG, Best JD, O'Neal DN, Jenkins AJ (May 2014). "Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia". Diabetes & Vascular Disease Research. 11 (4): 262–269. doi:10.1177/1479164114532963. PMID24853908. S2CID23326308.
Repessé X, Moldes M, Muscat A, Vatier C, Chetrite G, Gille T, Planes C, Filip A, Mercier N, Duranteau J, Fève B (Aug 2015). "Hypoxia inhibits semicarbazide-sensitive amine oxidase activity in adipocytes". Molecular and Cellular Endocrinology. 411: 58–66. doi:10.1016/j.mce.2015.04.011. PMID25907140. S2CID46505459.
Valente T, Gella A, Solé M, Durany N, Unzeta M (Oct 2012). "Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus". Journal of Neuroscience Research. 90 (10): 1989–96. doi:10.1002/jnr.23092. PMID22714978. S2CID26126297.
Hernandez-Guillamon M, Solé M, Delgado P, García-Bonilla L, Giralt D, Boada C, Penalba A, García S, Flores A, Ribó M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J (2012). "VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke". Cerebrovascular Diseases. 33 (1): 55–63. doi:10.1159/000333370. PMID22133888. S2CID24467635.
Solé M, Unzeta M (Nov 2011). "Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases". Biology of the Cell. 103 (11): 543–57. doi:10.1042/BC20110049. PMID21819380. S2CID4598444.
El-Maghrabey MH, Kishikawa N, Ohyama K, Imazato T, Ueki Y, Kuroda N (Jun 2015). "Determination of human serum semicarbazide-sensitive amine oxidase activity via flow injection analysis with fluorescence detection after online derivatization of the enzymatically produced benzaldehyde with 1,2-diaminoanthraquinone". Analytica Chimica Acta. 881: 139–47. Bibcode:2015AcAC..881..139E. doi:10.1016/j.aca.2015.04.006. hdl:10069/35501. PMID26041530.
Wong M, Saad S, Zhang J, Gross S, Jarolimek W, Schilter H, Chen JA, Gill AJ, Pollock CA, Wong MG (Oct 2014). "Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model". American Journal of Physiology. Renal Physiology. 307 (8): F908–16. doi:10.1152/ajprenal.00698.2013. PMID25143459.
Sun P, Solé M, Unzeta M (2014). "Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia". Cerebrovascular Diseases. 37 (3): 171–80. doi:10.1159/000357660. PMID24503888. S2CID11980778.
Lin MS, Li HY, Wei JN, Lin CH, Smith DJ, Vainio J, Shih SR, Chen YH, Lin LC, Kao HL, Chuang LM, Chen MF (Nov 2008). "Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease". Clinical Biochemistry. 41 (16–17): 1362–7. doi:10.1016/j.clinbiochem.2008.06.019. PMID18644360.
Kaplan MA, Kucukoner M, Inal A, Urakci Z, Evliyaoglu O, Firat U, Kaya M, Isikdogan A (2014). "Relationship between serum soluble vascular adhesion protein-1 level and gastric cancer prognosis". Oncology Research and Treatment. 37 (6): 340–4. doi:10.1159/000362626. PMID24903765. S2CID22849102.
Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S (Aug 2008). "Vascular adhesion protein-1 in human ischaemic stroke". Neuropathology and Applied Neurobiology. 34 (4): 394–402. doi:10.1111/j.1365-2990.2007.00911.x. PMID18005095. S2CID25254193.
Li HY, Wei JN, Lin MS, Smith DJ, Vainio J, Lin CH, Chiang FT, Shih SR, Huang CH, Wu MY, Hsein YC, Chuang LM (Jun 2009). "Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia". Clinica Chimica Acta; International Journal of Clinical Chemistry. 404 (2): 149–53. doi:10.1016/j.cca.2009.03.041. PMID19336232.
ncbi.nlm.nih.gov
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Foot JS, Yow TT, Schilter H, Buson A, Deodhar M, Findlay AD, Guo L, McDonald IA, Turner CI, Zhou W, Jarolimek W (Nov 2013). "PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo". The Journal of Pharmacology and Experimental Therapeutics. 347 (2): 365–74. doi:10.1124/jpet.113.207613. PMID23943052. S2CID6164890.
Januszewski AS, Mason N, Karschimkus CS, Rowley KG, Best JD, O'Neal DN, Jenkins AJ (May 2014). "Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia". Diabetes & Vascular Disease Research. 11 (4): 262–269. doi:10.1177/1479164114532963. PMID24853908. S2CID23326308.
Repessé X, Moldes M, Muscat A, Vatier C, Chetrite G, Gille T, Planes C, Filip A, Mercier N, Duranteau J, Fève B (Aug 2015). "Hypoxia inhibits semicarbazide-sensitive amine oxidase activity in adipocytes". Molecular and Cellular Endocrinology. 411: 58–66. doi:10.1016/j.mce.2015.04.011. PMID25907140. S2CID46505459.
Valente T, Gella A, Solé M, Durany N, Unzeta M (Oct 2012). "Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus". Journal of Neuroscience Research. 90 (10): 1989–96. doi:10.1002/jnr.23092. PMID22714978. S2CID26126297.
Hernandez-Guillamon M, Solé M, Delgado P, García-Bonilla L, Giralt D, Boada C, Penalba A, García S, Flores A, Ribó M, Alvarez-Sabin J, Ortega-Aznar A, Unzeta M, Montaner J (2012). "VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke". Cerebrovascular Diseases. 33 (1): 55–63. doi:10.1159/000333370. PMID22133888. S2CID24467635.
Solé M, Unzeta M (Nov 2011). "Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases". Biology of the Cell. 103 (11): 543–57. doi:10.1042/BC20110049. PMID21819380. S2CID4598444.
Sun P, Solé M, Unzeta M (2014). "Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia". Cerebrovascular Diseases. 37 (3): 171–80. doi:10.1159/000357660. PMID24503888. S2CID11980778.
Kaplan MA, Kucukoner M, Inal A, Urakci Z, Evliyaoglu O, Firat U, Kaya M, Isikdogan A (2014). "Relationship between serum soluble vascular adhesion protein-1 level and gastric cancer prognosis". Oncology Research and Treatment. 37 (6): 340–4. doi:10.1159/000362626. PMID24903765. S2CID22849102.
Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S (Aug 2008). "Vascular adhesion protein-1 in human ischaemic stroke". Neuropathology and Applied Neurobiology. 34 (4): 394–402. doi:10.1111/j.1365-2990.2007.00911.x. PMID18005095. S2CID25254193.